Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.pharmaids.com | |
Market Cap | 58.87 Cr. | |
Enterprise Value(EV) | 59.87 Cr. | 2022-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | -0.31 | Trailing Twelve Months Ending 2022-09 |
Price-Earning Ratio (PE) | - | Trailing Twelve Months Ending 2022-09 |
Industry PE | 32.90 | Trailing Twelve Months Ending 2022-09 |
Book Value / Share | 13.49 | Trailing Twelve Months Ending 2022-09 |
Price to Book Value | 2.03 | Calculated using Price: 27.40 |
Dividend Yield | 0.00 | Period Ending 2022-03 |
No. of Shares Subscribed | 2.15 Cr. | 21,486,234 Shares |
FaceValue | 10 | |
Company Profile | ||
The Company is engaged in the business of Trading and Manufacturing of Generics, Bulk Drugs and Intermediaries, etc. |
1 Day |
|
|
1 Week |
|
+4.98% |
1 Month |
|
-2.14% |
3 Month |
|
+100.73% |
6 Month |
|
+113.06% |
1 Year |
|
+83.89% |
2 Year |
|
+131.22% |
5 Year |
|
+911.07% |
10 Year |
|
+661.11% |
9 years | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
Return on Equity (%) | -17.79 | -3.71 | -26.21 | 7.99 | -31.24 | -3.76 | 0.40 | 1.10 | 1.69 | |
Return on Capital Employed (%) | -14.96 | -4.99 | -21.19 | 7.61 | -29.73 | -3.02 | -4.45 | 1.04 | 1.66 | |
Return on Assets (%) | -11.66 | -2.42 | -16.50 | 5.08 | -23.27 | -3.56 | 0.40 | 1.11 | 1.49 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09* Rs. Cr. |
Shh. Funds | 2 | 2 | 1 | 1 | 1 | 8 | 8 | 9 | 9 | 8 | |
Non Curr. Liab. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | |
Curr. Liab. | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 2 | 0 | |
Minority Int. | |||||||||||
Equity & Liab. | 3 | 3 | 2 | 2 | 1 | 9 | 8 | 9 | 11 | 9 | |
Non Curr. Assets | 1 | 1 | 1 | 0 | 1 | 4 | 8 | 8 | 8 | 8 | |
Curr. Assets | 2 | 2 | 2 | 2 | 1 | 4 | 0 | 1 | 3 | 1 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 3 | 3 | 2 | 2 | 1 | 9 | 8 | 9 | 11 | 9 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09 Rs. Cr. TTM |
Net Sales | 1 | 2 | 2 | 1 | 0 | 1 | 9 | 4 | 1 | ||
Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Total Income | 2 | 2 | 2 | 1 | 0 | 1 | 9 | 4 | 1 | ||
Total Expenditure | -2 | -2 | -2 | -2 | -1 | -1 | 0 | -8 | -4 | -2 | |
PBIDT | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1 | |
Interest | 0 | 0 | 0 | ||||||||
Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Taxation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
Exceptional Items | 1 | ||||||||||
PAT | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1 | |
Adjusted EPS | -1 | 0 | -1 | 0 | -1 | 0 | 0 | 0 | 0 | -1 |
Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Cash Fr. Operatn. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1 | 0 | 0 | |
Cash Fr. Inv. | 0 | 0 | 0 | 0 | 1 | 0 | 0 | ||||
Cash Fr. Finan. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
Net Change | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Cash & Cash Eqvt | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
Wed, 25 Jan 2023
Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements Intimation under Regulation 30 (LODR) for execution of Investment Agreement |
Mon, 23 Jan 2023
Announcement under Regulation 30 (LODR)-Resignation of Director Revised Intimation for resignation of Dr. Vyasmurti Madhavrao Shingatgeri (DIN: 07728757) as Independent Director of the Company with effect from the end of business hours of August 3 2022. |
Wed, 18 Jan 2023
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011 The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Shankarappa Nagaraja Vinaya Babu |
Mon, 23 Jan 2023 |
|
|
|
|
|